{"id":"https://openalex.org/W1990701533","doi":"https://doi.org/10.1056/nejmc0906670","title":"Aprepitant as an Antipruritic Agent?","display_name":"Aprepitant as an Antipruritic Agent?","alternate_titles":[],"publication_year":2009,"publication_date":"2009-09-30","ids":{"openalex":"https://openalex.org/W1990701533","doi":"https://doi.org/10.1056/nejmc0906670","mag":"1990701533","pmid":"https://pubmed.ncbi.nlm.nih.gov/19797294"},"language":"en","primary_location":{"id":"doi:10.1056/nejmc0906670","doi":"https://doi.org/10.1056/nejmc0906670","is_oa":true,"landing_page_url":"https://doi.org/10.1056/nejmc0906670","pdf_url":"https://www.nejm.org/doi/pdf/10.1056/NEJMc0906670?articleTools=true","source":{"id":"https://openalex.org/S62468778","display_name":"New England Journal of Medicine","issn_l":"0028-4793","issn":["0028-4793","0096-6762","1533-4406","2331-4710"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320239","host_organization_name":"Massachusetts Medical Society","host_organization_lineage":["https://openalex.org/P4310320239"],"host_organization_lineage_names":["Massachusetts Medical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"New England Journal of Medicine","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1990701533"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://www.nejm.org/doi/pdf/10.1056/NEJMc0906670?articleTools=true","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Arnaud Duval","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Arnaud Duval","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5105367142","display_name":"Louis Dubertret","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Louis Dubertret","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":10.3381,"has_fulltext":true,"cited_by_count":141,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.98722371,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":91,"max":100},"biblio":{"volume":"361","issue":"14","first_page":"1415","last_page":"1416"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11811","display_name":"Cutaneous lymphoproliferative disorders research","score":0.5557000041007996,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11811","display_name":"Cutaneous lymphoproliferative disorders research","score":0.5557000041007996,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10837","display_name":"Dermatology and Skin Diseases","score":0.399399995803833,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11117","display_name":"Drug-Induced Adverse Reactions","score":0.013899999670684338,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/aprepitant","display_name":"aprepitant","score":0.9470000267028809},{"id":"https://openalex.org/keywords/pruritus","display_name":"pruritus","score":0.8510000109672546},{"id":"https://openalex.org/keywords/antipruritic-agents","display_name":"antipruritic agents","score":0.8700000047683716},{"id":"https://openalex.org/keywords/sezary-syndrome","display_name":"S\u00e9zary syndrome","score":0.9369999766349792},{"id":"https://openalex.org/keywords/substance-p","display_name":"substance P","score":0.871999979019165},{"id":"https://openalex.org/keywords/nk1-receptor-antagonists","display_name":"NK1 receptor antagonists","score":0.9369999766349792},{"id":"https://openalex.org/keywords/cutaneous-t-cell-lymphoma","display_name":"cutaneous T-cell lymphoma","score":0.875},{"id":"https://openalex.org/keywords/adverse-drug-reactions","display_name":"adverse drug reactions","score":0.5410000085830688}],"concepts":[{"id":"https://openalex.org/C2780574406","wikidata":"https://www.wikidata.org/wiki/Q621834","display_name":"Aprepitant","level":4,"score":0.99507737159729},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8911721706390381},{"id":"https://openalex.org/C2776533618","wikidata":"https://www.wikidata.org/wiki/Q411041","display_name":"Substance P","level":4,"score":0.8669413328170776},{"id":"https://openalex.org/C2780852908","wikidata":"https://www.wikidata.org/wiki/Q127076","display_name":"Vomiting","level":2,"score":0.7309809327125549},{"id":"https://openalex.org/C2780580376","wikidata":"https://www.wikidata.org/wiki/Q186889","display_name":"Nausea","level":2,"score":0.7053273320198059},{"id":"https://openalex.org/C202871150","wikidata":"https://www.wikidata.org/wiki/Q12744608","display_name":"NK1 receptor antagonist","level":5,"score":0.6421351432800293},{"id":"https://openalex.org/C137130169","wikidata":"https://www.wikidata.org/wiki/Q15316325","display_name":"Tachykinin receptor 1","level":5,"score":0.606037437915802},{"id":"https://openalex.org/C2780938799","wikidata":"https://www.wikidata.org/wiki/Q2853347","display_name":"Antipruritic","level":2,"score":0.5853960514068604},{"id":"https://openalex.org/C2780884295","wikidata":"https://www.wikidata.org/wiki/Q575136","display_name":"Antiemetic","level":3,"score":0.5208818912506104},{"id":"https://openalex.org/C2776885963","wikidata":"https://www.wikidata.org/wiki/Q245204","display_name":"Antagonist","level":3,"score":0.4558694064617157},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.4451349675655365},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4410242736339569},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.4328910708427429},{"id":"https://openalex.org/C2778122271","wikidata":"https://www.wikidata.org/wiki/Q410943","display_name":"Receptor antagonist","level":4,"score":0.43063902854919434},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.29733264446258545},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.25130125880241394},{"id":"https://openalex.org/C118303440","wikidata":"https://www.wikidata.org/wiki/Q419968","display_name":"Neuropeptide","level":3,"score":0.205989271402359}],"mesh":[{"descriptor_ui":"D000077608","descriptor_name":"Aprepitant","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000932","descriptor_name":"Antiemetics","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009025","descriptor_name":"Morpholines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D011537","descriptor_name":"Pruritus","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D011537","descriptor_name":"Pruritus","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false},{"descriptor_ui":"D012751","descriptor_name":"Sezary Syndrome","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":true},{"descriptor_ui":"D012878","descriptor_name":"Skin Neoplasms","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":true},{"descriptor_ui":"D064729","descriptor_name":"Neurokinin-1 Receptor Antagonists","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1056/nejmc0906670","doi":"https://doi.org/10.1056/nejmc0906670","is_oa":true,"landing_page_url":"https://doi.org/10.1056/nejmc0906670","pdf_url":"https://www.nejm.org/doi/pdf/10.1056/NEJMc0906670?articleTools=true","source":{"id":"https://openalex.org/S62468778","display_name":"New England Journal of Medicine","issn_l":"0028-4793","issn":["0028-4793","0096-6762","1533-4406","2331-4710"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320239","host_organization_name":"Massachusetts Medical Society","host_organization_lineage":["https://openalex.org/P4310320239"],"host_organization_lineage_names":["Massachusetts Medical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"New England Journal of Medicine","raw_type":"journal-article"},{"id":"pmid:19797294","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19797294","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The New England journal of medicine","raw_type":"Case Reports"}],"best_oa_location":{"id":"doi:10.1056/nejmc0906670","doi":"https://doi.org/10.1056/nejmc0906670","is_oa":true,"landing_page_url":"https://doi.org/10.1056/nejmc0906670","pdf_url":"https://www.nejm.org/doi/pdf/10.1056/NEJMc0906670?articleTools=true","source":{"id":"https://openalex.org/S62468778","display_name":"New England Journal of Medicine","issn_l":"0028-4793","issn":["0028-4793","0096-6762","1533-4406","2331-4710"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320239","host_organization_name":"Massachusetts Medical Society","host_organization_lineage":["https://openalex.org/P4310320239"],"host_organization_lineage_names":["Massachusetts Medical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"New England Journal of Medicine","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W1990701533.pdf","grobid_xml":"https://content.openalex.org/works/W1990701533.grobid-xml"},"referenced_works_count":5,"referenced_works":["https://openalex.org/W1969328421","https://openalex.org/W1993434718","https://openalex.org/W2052325071","https://openalex.org/W2108810525","https://openalex.org/W2122811674"],"related_works":["https://openalex.org/W2099873769","https://openalex.org/W4244087130","https://openalex.org/W2068736424","https://openalex.org/W4310754324","https://openalex.org/W2755290839","https://openalex.org/W2596094198","https://openalex.org/W4400313816","https://openalex.org/W2888346002","https://openalex.org/W2171587188","https://openalex.org/W4328006786"],"abstract_inverted_index":{"To":[0],"the":[1,18,38],"Editor:":[2],"The":[3],"Sezary":[4],"syndrome":[5],"is":[6,29,54,60,86],"a":[7,30,76,88],"leukemic,":[8],"cutaneous,":[9],"epidermotropic":[10],"T-cell":[11],"lymphoma.":[12],"Pruritus,":[13],"insomnia,":[14],"and":[15,22,70],"depression":[16],"impair":[17],"quality":[19],"of":[20,33,40,92],"life":[21],"can":[23],"lead":[24],"to":[25],"suicide.1":[26],"Substance":[27],"P":[28],"key":[31],"mediator":[32],"pruritus.2":[34],"An":[35],"increase":[36],"in":[37,49,67,79],"expression":[39],"its":[41,73],"receptor,":[42],"neurokinin-1,":[43],"has":[44],"been":[45],"reported":[46],"on":[47,97],"keratinocytes":[48],"pruritic":[50],"skin":[51],"diseases.3":[52],"Aprepitant":[53],"an":[55,64],"oral":[56],"neurokinin-1\u2013receptor":[57],"antagonist.4":[58],"It":[59],"widely":[61],"used":[62],"as":[63],"antiemetic":[65],"agent":[66],"chemotherapy-induced":[68],"nausea":[69],"vomiting.5":[71],"However,":[72],"action":[74],"suggests":[75],"potential":[77],"reduction":[78],"substance":[80],"P\u2013induced":[81],"pruritus,":[82],"even":[83],"though":[84],"pruritus":[85],"considered":[87],"rare":[89],"side":[90],"effect":[91],"this":[93],"drug.":[94],"We":[95],"report":[96],"three":[98],"patients":[99],".\u00a0.\u00a0.":[100]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1990701533","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":7},{"year":2023,"cited_by_count":6},{"year":2022,"cited_by_count":6},{"year":2021,"cited_by_count":6},{"year":2020,"cited_by_count":9},{"year":2019,"cited_by_count":16},{"year":2018,"cited_by_count":15},{"year":2017,"cited_by_count":7},{"year":2016,"cited_by_count":12},{"year":2015,"cited_by_count":8},{"year":2014,"cited_by_count":7},{"year":2013,"cited_by_count":11},{"year":2012,"cited_by_count":8}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
